Outcome of Primary Mediastinal Large B Cell Lymphoma Treated with RCHOP.
Khalid HalahlehAbeer YaseenIsra MuradiAkram Al-IbraheemIyad SultanMohammad Ma'kosehPublished in: Journal of blood medicine (2023)
In PMLBCL, RCHOP chemotherapy backbone in the frontline therapy is suboptimal but can be used in patients with low IPI. Adapting more intensive chemoimmunotherapy regimens may be considered for patients with high IPI. Salvage chemotherapy has limited activity in patients with relapsed or refractory disease.